ILOMEDIN

This brand name is authorized in Austria, Cyprus, Estonia, Finland, Hong Kong SAR China, Malta, New Zealand, Romania, Spain, Turkey, UK.

Active ingredients

The drug ILOMEDIN contains one active pharmaceutical ingredient (API):

1	Iloprost trometamol UNII 807T91913V - ILOPROST TROMETHAMINE
	Iloprost is a synthetic prostacyclin analogue. After inhalation of iloprost direct vasodilatation of the pulmonary arterial bed occur with consecutive significant improvement of pulmonary artery pressure, pulmonary vascular resistance and cardiac output as well as mixed venous oxygen saturation.
	Read more about Iloprost

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ILOMEDIN Solution for infusion	MPI, EU: SmPC	Medicines and Medical Devices Safety Authority (NZ)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B01AC11	Iloprost	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1389843, 1523775, 1685189, 1728480, 1781445, 1785023
ES	Centro de información online de medicamentos de la AEMPS	61596
FI	Lääkealan turvallisuus- ja kehittämiskeskus	585216
GB	Medicines & Healthcare Products Regulatory Agency	387198
HK	Department of Health Drug Office	50560
MT	Medicines Authority	AA729/32401
NZ	Medicines and Medical Devices Safety Authority	5423
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W63884001, W63884002
TR	İlaç ve Tıbbi Cihaz Kurumu	8699546757794, 8699546758807